Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Humana Inc (HUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012226
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and services include Medicare Advantage plan, prescription drug plan, Medicare supplement insurance plans, group Medicare advantage plan and Medicare plan tools. It offers products and services for individual and family including medical plans, dental plans, vision plans, life insurance and life and supplemental plans, among others. The company sells its products in the US through direct sales representatives and telemarketing representatives, licensed independent brokers and agents and marketing arrangement with Wal-Mart Stores, Inc. Humana is headquartered in Louisville, Kentucky, the US.

Humana Inc (HUM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Humana Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Venture Financing 17
Omada Health Raises USD48 Million in Series C Financing 17
Partnerships 19
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Equity Offering 22
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Acquisition 23
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc – Key Competitors 35
Humana Inc – Key Employees 36
Humana Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 43
Strategy And Business Planning 43
May 10, 2017: Humana Brings Value-Based Orthopedic Specialty Care to North Carolina and Virginia 43
May 18, 2016: Humana Brings Value-Based Orthopaedic Specialty Care Model to Tennessee, Expands in Ohio 44
Financial Announcements 45
Nov 08, 2017: Humana Reports Third Quarter 2017 Financial Results 45
Aug 02, 2017: Humana Reports Second Quarter 2017 Financial Results; Raises Full Year 2017 Guidance; Provides Update on Bonus Year 2018 Star Ratings 47
May 03, 2017: Humana Reports Detailed First Quarter Financial Results; Reaffirms Recent Full-Year 2017 EPS Guidance Increase 48
Apr 24, 2017: Humana Pre-announces First Quarter 2017 EPS and Revenues and Increases Full-year 2017 EPS Guidance 49
Feb 08, 2017: Humana Reports Fourth Quarter 2016 Financial Results 50
Nov 04, 2016: Humana Reports Third Quarter 2016 Financial Results 53
Aug 19, 2016: Humana announces financial results for interim period January-June 2016 60
Aug 03, 2016: Humana Reports Second Quarter 2016 Financial Results; Reaffirms Recent 2016 Financial Guidance Increase 64
Jul 21, 2016: Humana Increases Earnings Guidance 74
May 04, 2016: Humana Reports First Quarter 2016 Financial Results; Reaffirms 2016 Financial Guidance 76
Feb 10, 2016: Humana Reports Fourth Quarter 2015 Financial Results; Provides 2016 Financial Guidance 78
Corporate Communications 79
Nov 13, 2017: Humana Elects Karen DeSalvo, M.D., to Board of Directors 79
Aug 21, 2017: Humana appoints new member to board of directors 80
Jun 23, 2017: Humana Names Sam Deshpande Chief Risk Officer 81
Apr 27, 2016: Humana Research on Medication Adherence and Medicare Advantage Wins Prestigious Awards 82
Mar 10, 2016: Humana Named No. 1 U.S. Health Care Company in Leading National Assessment of Corporate Sustainability Efforts 83
Government and Public Interest 84
Jul 18, 2017: Humana Foundation Awards $735,000 to South Florida Nonprofits to Improve Health of Community 84
Jul 12, 2016: Humana Approved for $3.6 Million Research Funding Award by the Patient-Centered Outcomes Research Institute 86
Product News 87
Feb 02, 2017: Study Finds Omada Diabetes Prevention Program Resulted in 7.5% Weight Loss in Humana Medicare Advantage Population 87
Other Significant Developments 88
Oct 26, 2017: New Study Finds Healthy Days Valid Tool for Evaluating Population Health in Medicare Advantage Patients with Chronic Conditions 88
Oct 17, 2017: Humana Expands Medicare Advantage Offerings in New Hampshire 89
Dec 14, 2016: Humana Simplifies Clinical Quality Metrics to Ease Growing Reporting Demands Placed on Physicians 90
Nov 28, 2016: Humana to Add JSA Medical Group’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Florida Medicare Advantage Plan Networks 91
Nov 07, 2016: Humana Adds Telemedicine Technology Benefit in Medicare Advantage Plans Available in Georgia and South Carolina 93
Oct 28, 2016: Humana to Add EliteHealth’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to South Florida Medicare Advantage Plan Networks 94
Oct 13, 2016: Humana to Add Iora Health’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Medicare Advantage Plan Networks in Arizona, Colorado and Washington 96
Oct 12, 2016: Humana Comments on Medicare Star Quality Ratings and Raises 2016 Financial Guidance 97
Jun 16, 2016: Humana and Mount Sinai Health Partners Create Improved Care Model 99
May 05, 2016: Hennepin County Medical Center Partnering with Humana on Value-Based Care Initiative 100
Mar 10, 2016: Humana Launches Value-Based Orthopedic Specialty Care Model in Ohio 101
Mar 03, 2016: Humana, DeKalb Medical and DeKalb Physician Hospital Organization Now Offer Value-based Care to Commercial Members 102
Appendix 103
Methodology 103
About GlobalData 103
Contact Us 103
Disclaimer 103

List of Tables
Humana Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Omada Health Raises USD48 Million in Series C Financing 17
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc, Key Competitors 35
Humana Inc, Key Employees 36
Humana Inc, Other Locations 37
Humana Inc, Subsidiaries 40

★海外企業調査レポート[Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Serina Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a pharmaceutical company that develops therapeutics for cancer, neurological diseases, pain and metabolic disorders. The company’s pipeline products include SER-214, SER-227, SER-228, SER-232, and other proprietary drugs. It uses proprietary t …
  • Toromont Industries Ltd:企業の戦略・SWOT・財務情報
    Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Martin Midstream Partners LP (MMLP):企業の財務・戦略的SWOT分析
    Martin Midstream Partners LP (MMLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Landis+Gyr AG-エネルギー分野:企業M&A・提携分析
    Summary Landis+Gyr AG (Landis+Gyr) is an integrated energy management company that provide end-to-end advanced metering solutions. It delivers comprehensive services including cloud services, managed services, smart grid services, software services, solutions consulting and support services. The com …
  • AirStrip Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform, accelerator services and wireless maternal-fetal monitoring solutions. It caters its products to healthcare provide …
  • Optiscan Imaging Limited (OIL)-医療機器分野:企業M&A・提携分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • Green Plains Inc.:企業の戦略・SWOT・財務情報
    Green Plains Inc. - Strategy, SWOT and Corporate Finance Report Summary Green Plains Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lava Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Lava Therapeutics BV (Lava Therapeutics) is a biotechnology company which develops immune oncology biopharmaceuticals products. Its proprietary V?9Vd2 T-cell engager candidates bind to the conserved (monomorphic) T-cell receptor of V?9Vd2 T-cells which exhibit potent cytotoxicity, interferon …
  • AiCuris GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary AiCuris GmbH & Co KG (AiCuris) a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents f …
  • Avacta Group Plc (AVCT):企業の製品パイプライン分析2018
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Danieli & C. Officine Meccaniche SpA:企業の戦略・SWOT・財務分析
    Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report Summary Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • moksha8 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Moksha8 Pharmaceuticals Inc (Moksha8) is a specialty pharmaceutical company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. Moksha8 commercialize a portfolio of …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Deep Down Inc (DPDW):企業の財務・戦略的SWOT分析
    Summary Deep Down Inc (Deep Down) is a subsea oilfield services company that offers exploration and production support products and services. The company provides products such as active heave compensator, asset wellness, bend limiters, bend stiffener latcher, buoyancy modules, carousels, dynamic po …
  • Tate & Lyle PLC:企業のM&A・事業提携・投資動向
    Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Elixir Energy Ltd (EXR):企業の財務・戦略的SWOT分析
    Summary Elixir Energy Ltd (Elixir Energy) is an independent oil and gas exploration and production company that acquires, explores, and develops conventional and unconventional oil and gas properties. The company's projects include Petra project, Wattenberg project, and Moselle Permit. Its Petra pro …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Croatia Airlines d.d.:企業の戦略・SWOT・財務情報
    Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆